The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease characterized by scar formation and respiratory insufficiency, which progressively leads to death. Pulmonary hypertension (PH) is a common complication of IPF that negatively impacts clinical outcomes, and has been classified as Group III...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathinasabapathy, Anandharajan, Horowitz, Alana, Horton, Kelsey, Kumar, Ashok, Gladson, Santhi, Unger, Thomas, Martinez, Diana, Bedse, Gaurav, West, James, Raizada, Mohan K., Steckelings, Ulrike M., Sumners, Colin, Katovich, Michael J., Shenoy, Vinayak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881224/
https://www.ncbi.nlm.nih.gov/pubmed/29636695
http://dx.doi.org/10.3389/fphys.2018.00180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881224/
https://www.ncbi.nlm.nih.gov/pubmed/29636695
http://dx.doi.org/10.3389/fphys.2018.00180

Ejemplares similares